A significant part of the cannabis ecosystem is research and development. Biotech, pharma and medical technology companies are developing strains, formulations, delivery methods and digital tools based on cannabis. Many of these projects involve clinical trials with human participants, and almost all involve sensitive professional work with high stakes.
Cannabis businesses store and process highly sensitive data. Patient records, prescriptions, treatment histories, purchasing data and full supply chain tracking all live in interconnected systems. At the same time, operations rely on seed to sale platforms, smart greenhouses, security systems and electronic payment solutions.
A cyber incident in this environment is not only an IT issue. It can trigger regulatory scrutiny, privacy claims, business interruption and reputational damage.
D&O insurance for cannabis companies is built to protect the people who take these decisions and the organization itself from costly and complex legal actions.
Cannabis crop, stock and living plant insurance is designed to protect exactly that asset. It is not just another property policy, but a specific response to a business where the core asset is a sensitive crop with a clear life cycle.
Cannabis product liability and recall insurance is one of the central building blocks of any serious insurance program for cultivators, processors and brand owners.
The cannabis industry combines three demanding worlds in one. Advanced agriculture, pharmaceutical level regulation and technology driven operations, all under close scrutiny from regulators, investors and the public. From seed to sale, every stage of the chain carries its own risk profile and its own expectations for governance and compliance.
IMI Insurance stands for Insurance for Medical Institutions or Insurance for Medical Innovation, and refers to a tailored group of insurance products designed to protect companies and organizations operating in the healthcare, biotech, and medical technology sectors. This includes hospitals, clinics, laboratories, clinical trial sponsors, and medical device manufacturers.
Medical research laboratories are often at the forefront of innovation, working with sensitive technologies and engaging in collaborations with hospitals, academic institutions, and pharmaceutical companies. From pre-clinical experiments and in-vitro testing to genetic data analysis and advanced medical trials — the operational and professional risks faced by labs are high and require specialized insurance coverage.
The role of investment managers is pivotal in today’s financial landscape. With significant growth in Israeli investments globally—approximately $16.5 billion in real estate alone between 2017 and 2022—managing client portfolios effectively is more critical than ever. However, the dual responsibility of maximizing client returns while adhering to stringent regulatory requirements exposes investment managers to significant risks.
The research and development (R&D) sector is at the forefront of innovation, driving technological and scientific progress across industries. However, the nature of R&D work involves significant risks, from intellectual property disputes to liabilities stemming from testing or prototype failures. Comprehensive insurance solutions are essential for safeguarding your operations and enabling your business to thrive in a competitive landscape.
Food supplement companies are engaged in the production of food supplements/marketing of food supplements for institutional and private customers.
Our insurance program for food supplement companies is adapted to all company stages, from R&D to sales. Alternatively, there is a dedicated insurance plan for distributors only. The insurance plans have global coverage and provide spatial protection for the company in each phase. Our insurance specifications are individually tailored to each and every company, taking full account of investor and customer requirements.
Research and development companies dealing in various fields, such as drug development, medical device development, consultants, and CROs, are exposed to lawsuits for financial damages
Leave us your details
and we'll get back to you as soon as possible
Leave us your details
and we'll get back to you as soon as possible